"FDA Advisers Tackle Ethical and Logistical Challenges of Artificial Womb Technology"

Independent advisers to the U.S. Food and Drug Administration (FDA) are discussing the regulations, ethics, and possibilities of creating an artificial womb to increase the survival chances of extremely premature babies without long-term health problems. While no such device has been tested in humans, similar ones have been used successfully in animals. Prematurity is the leading cause of death in children under 5, and an artificial womb could help address this issue. The FDA committee is considering the data and regulations required for human trials, as well as ethical considerations and long-term effects. The FDA makes its own decisions and is not bound by the advisers' recommendations.